Shopping Cart
Remove All
Your shopping cart is currently empty
Avibactam tomilopil (AV-006) is an orally bioavailable prodrug of Avibactam and functions as a β-lactamase inhibitor. Avibactam tomilopil effectively releases Avibactam, which inhibits class A and C β-lactamases, including extended-spectrum β-lactamases (ESBLs), AmpC enzymes, and Klebsiella pneumoniae carbapenemase (KPC), thereby broadening antibacterial coverage.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $108 | - | In Stock | |
| 2 mg | $158 | - | In Stock | |
| 5 mg | $265 | - | In Stock | |
| 10 mg | $430 | - | In Stock | |
| 25 mg | $810 | - | In Stock | |
| 50 mg | Preferential | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $292 | - | In Stock |
| Description | Avibactam tomilopil (AV-006) is an orally bioavailable prodrug of Avibactam and functions as a β-lactamase inhibitor. Avibactam tomilopil effectively releases Avibactam, which inhibits class A and C β-lactamases, including extended-spectrum β-lactamases (ESBLs), AmpC enzymes, and Klebsiella pneumoniae carbapenemase (KPC), thereby broadening antibacterial coverage. |
| In vivo | Avibactam tomilopil is an orally administered prodrug that is converted into the active ingredient Avibactam in vivo. When used in combination with Ceftibuten, Avibactam protects this β-lactam antibiotic from degradation by inhibiting enzymes produced by Gram-negative bacteria, thereby exerting synergistic antibacterial effects. [1] |
| Synonyms | AV-006, AV006, ARX-1796, ARX1796 |
| Molecular Weight | 393.41 |
| Formula | C14H23N3O8S |
| Cas No. | 2245880-46-8 |
| Smiles | C(N)(=O)[C@H]1[N@@]2C(=O)N(OS(OCC(C(OCC)=O)(C)C)(=O)=O)[C@@](C2)(CC1)[H] |
| Color | Yellow |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (203.35 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (8.39 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.